Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma.
D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D018893:Bronchoalveolar Lavage; D002384:Catalysis; D016923:Cell Death; D002465:Cell Movement; D054426:Chemokine CXCL2; D018925:Chemokines / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D015536:Down-Regulation; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D016753:Interleukin-10 / Q000378:metabolism; D018664:Interleukin-12 / Q000378:metabolism; D018793:Interleukin-13 / Q000378:metabolism; D015848:Interleukin-5 / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008168:Lung / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000378:metabolism / Q000494:pharmacology; D009195:Peroxidase / Q000378:metabolism; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D054426:Chemokine CXCL2; D018925:Chemokines; C404915:Cxcl2 protein, mouse; D016207:Cytokines; D004791:Enzyme Inhibitors; D018793:Interleukin-13; D015848:Interleukin-5; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D018664:Interleukin-12; D010047:Ovalbumin; D009195:Peroxidase